Stereotactic body radiotherapy for T1 glottic cancer: dosimetric data in 27 consecutive patients.

Giuseppe SanguinetiRaul PelliniAntonello VidiriSimona MarziPasqualina D'UrsoIrene TerrenatoAlessia FarnetiValentina FugaSara UnganiaValeria Landoni

Published in: Tumori (2021)

SBRT in 3 fractions for T1 glottic lesions is dosimetrically challenging. Clinical validation is awaited.

Keyphrases